HIGHLIGHTS
- who: Melanie Casile from the Icahn School of Medicine at Mount Sinai, United States University Hospital, Spain have published the article: hPG80 (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study, in the Journal: (JOURNAL)
- what: In this study, the levels of hPG80 (circulating progastrin) were determined in 11 different epithelial and non-epithelial cancers (colorectal, breast, uterus, ovary, prostate, kidney, pancreas, esophagus/stomach, liver, melanoma and lung). This study shows that hPG80 is expressed in the blood of patients with all types of cancers at significantly higher concentrations than . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.